NDC 0338-8402-01 - TISSEEL Fibrin Sealant
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0338-8402
- Requested NDC
- 0338-8402-01
- Package NDCs from labels
- 0338-8402-01, 0338-8402-02, 0338-8402-03, 0338-8402-04, 0338-8402-09, 0338-8402-10
- Manufacturer
- Baxter Healthcare Corporation
- Effective date
- 2025-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TISSEEL Fibrin Sealant - Baxter Healthcare Corporation | Baxter Healthcare Corporation | 2025-09-30 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0338-8402-01 | TISSEELFibrin Sealant | 2 mL in 1 SYRINGE, PLASTIC | SOLUTION | 2 | 9 | |
| 0338-8402-02 | TISSEELFibrin Sealant | 1 in 1 CARTON | SOLUTION | 1 | 9 | |
| 0338-8402-03 | TISSEELFibrin Sealant | 4 mL in 1 SYRINGE, PLASTIC | SOLUTION | 4 | 9 | |
| 0338-8402-04 | TISSEELFibrin Sealant | 1 in 1 CARTON | SOLUTION | 1 | 9 | |
| 0338-8402-09 | TISSEELFibrin Sealant | 10 mL in 1 SYRINGE, PLASTIC | SOLUTION | 10 | 9 | |
| 0338-8402-10 | TISSEELFibrin Sealant | 1 in 1 CARTON | SOLUTION | 1 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0338-8402 | TISSEEL FIBRIN SEALANT (FIBRINOGEN HUMAN, HUMAN THROMBIN) KIT TISSEEL FIBRIN SEALANT (FIBRINOGEN HUMAN, HUMAN THROMBIN) SOLUTION [BAXTER HEALTHCARE CORPORATION] | 8 | Legacy NDC, 6 package rows | 20240802_b3f69e25-1b87-4507-81fa-582ea084673d.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0338-8402-01 | ML - Milliliter | 0338-8402 | cbf2520f-e91d-44fa-a468-64bd4e21cbe3 | 1 | 2022-06-06 |
| 0338-8402-02 | ML - Milliliter | 0338-8402 | 95155609-93b5-4cc5-9907-8c99429aef28 | 1 | 2018-01-12 |
| 0338-8402-03 | ML - Milliliter | 0338-8402 | 53cca17c-cdbe-42fb-a3c0-cd18878c3fbe | 1 | 2022-06-06 |
| 0338-8402-04 | ML - Milliliter | 0338-8402 | 18b1ebf7-b9ce-41a9-8593-0bdaefd9efd9 | 1 | 2018-01-12 |
| 0338-8402-09 | ML - Milliliter | 0338-8402 | b6027cf3-c779-4169-8fce-e438b0ba32e6 | 1 | 2022-06-06 |
| 0338-8402-10 | ML - Milliliter | 0338-8402 | ab4c2acb-d2d6-406f-bd13-b1e43ce263ca | 1 | 2018-01-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SFERANGS VITA C CAPSULEBOOSTER | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22c67a6-1841-2419-e053-2995a90a9192 | 2020-03-31 | Warnings | 25X51I8RD4 |
| XYCOS PINK COLLAGEN | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22c9f95-e3ab-bfd3-e053-2995a90a3c66 | 2020-03-31 | Warnings | 25X51I8RD4 |
| XYCOS PINK COLLAGEN SERUM | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22d3cad-f8e7-7339-e053-2a95a90af8a4 | 2020-03-31 | Warnings | 25X51I8RD4 |
| XYCOS PINK COLLAGEN TONER | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22d5d31-4c3f-651c-e053-2a95a90ae541 | 2020-03-31 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE ROSE HEAVEN | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21c097c-82ac-3a21-e053-2995a90a63eb | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Rose HeavenCream | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21ba34c-2d2d-8033-e053-2995a90a1d74 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE ROSE HEAVEN SERUM | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21c72f8-00ff-0971-e053-2995a90a2f97 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital BrightCream | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21cbf42-482c-2d95-e053-2a95a90a1a48 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright Emulsion | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d0eba-a96c-72e8-e053-2995a90addfb | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright EyeCream | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d3c87-0a7f-2e15-e053-2a95a90aee69 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital BrightSerum | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d8184-258f-679e-e053-2995a90ad7c4 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright Toner | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21daae8-98d6-203a-e053-2a95a90aafe5 | 2020-03-30 | Warnings | 25X51I8RD4 |
| Dextrose and Electrolyte No. 48 | SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Company | b283a454-0c20-4fbf-92d3-dae1f3cd3cad | 2020-02-13 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | fbc01464-8885-4075-af41-911ffec5ae92 | 2020-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 5c7d3287-883a-459b-9214-074a583c8a59 | 2019-11-18 | B22547B95K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.